5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The ECG telemetry devices market is segmented by product, covering event monitoring and MCT (mobile cardiac telemetry), and other products (implantable loop recorder). It is also segmented by application and geography.
Fastest Growing Market:
The global population is around 7.5 billion, and it is increasing. Along with the rising population, the number of older people is also increasing, and the number of deaths due to cardiovascular diseases is on the rise.
ECG telemetry devices are used in the monitoring of electrical activities of the heart. These devices help in the detection of electrical impulses generated by cardiac tissues, which are then translated into waveforms.
|Event Monitoring and MCT (Mobile Cardiac Telemetry)|
|Other Products (Implantable Loop Recorder)|
|Myocardial Ischemia and Infarction|
Report scope can be customized per your requirements. Click here.
An electrocardiogram is one of the most useful non-invasive tools used for the diagnoses of cardiac diseases. Owing to the developments in telecommunication infrastructure, several developments were made in the field of telemetry cardiac devices. Telemetry ECG devices help in the easy and fast ECG monitoring of patients suffering from cardiac disorders.
Arrhythmia is a condition, in which the heart rhythm becomes abnormal. The electrical impulses occur too fast or too slow, leading to the reduced efficiency of the heart to pump blood. For the diagnoses of arrhythmias, various devices are used. However, ECG telemetry devices are the most effective tools for the detection of arrhythmias. As per the Centers for Disease Control and Prevention (CDC), around 2.7-6.1 million people in the United States suffer from arrhythmias, and with the rapid increase in the aging population, this number is expected to rise in the future. In the United States, around 2% of the population below the age of 65 and 9% above the age of 65 suffer from arrhythmias.
As the prevalence of arrhythmia is expected to rise, the need for better diagnostic tools is increasing. Hence, ECG telemetry devices are of much significance, as they provide easier and faster monitoring of the heart.
To understand key trends, Download Sample Report
Cardiovascular diseases are the major cause of deaths in the United States and the primary cause of acute care and physician visits.
According to the Centers for Disease Control and Prevention (CDC), in the United States, cardiovascular diseases cause around 610,000 deaths, every year, and these diseases account for almost one in every four deaths.
Every year, about 735,000 people suffer from heart attacks. Thus, the rise in the number of cardiovascular diseases (CVDs) and heart attacks lead to an increased demand for diagnostic tools, in the country.
The cardiovascular diagnostic sector prefers ECG telemetry devices, as they are the easiest and fastest tools for the diagnoses of CVDs. The United States provides good reimbursement facilities for patients suffering from cardiovascular diseases. This factor is helping the growth of the ECG telemetry devices market. In the United States, government initiatives, such as ‘A Public Health Action Plan to Prevent Heart Disease and Stroke’, are also increasing the utilization of novel technologies. This is ultimately contributing to the growth of the ECG telemetry devices market in the United States.
Additionally, investments in patient healthcare are increasing in the United States, which is ultimately helping the growth of the ECG telemetry devices market. Currently, the United States dominates the ECG telemetry devices market, and it had the largest market size in 2017.
To understand geography trends, Download Sample Report.
The ECG telemetry devices market is highly competitive, and there are multiple companies that are doing well in the market. However, some of the companies are contributing the most to this market and dominating certain geographies. With the rising focus on product development and the increasing usage of technology in healthcare, more small and mid-sized companies are expeced to enter the market in the future.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Cardiovascular Disease Rates
4.2.2 Technological Advancements in Remote Monitoring Technologies
4.3 Market Restraints
4.3.1 Cost Constraint
4.3.2 Complex Reimbursement Policies
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1.1 Event Monitoring and MCT (Mobile Cardiac Telemetry)
5.1.2 Other Products (Implantable Loop Recorder)
5.2.2 Myocardial Ischemia and Infarction
5.2.3 Pacemaker Monitoring
5.2.4 Other Applications
5.3.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.3.4 Middle East & Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle East & Africa
5.3.5 South America
18.104.22.168 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Aerotel Medical Systems Ltd
6.1.2 BioTelemetry Inc.
6.1.3 GE Healthcare Inc.
6.1.4 Medtronic Inc.
6.1.5 iRhythm Technologies Inc.
6.1.6 Nihon Kohden Corporation
6.1.7 Philips Healthcare
6.1.8 Medicalgorithmics SA
6.1.9 Preventice Solutions Inc.
6.1.10 Hill-Rom Services Inc. (Welch Allyn)
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments